Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - Annals of Oncology
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies | British Journal of Cancer
Frontiers | Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
xmlinkhub
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program | Journal for ImmunoTherapy of Cancer
Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer – Consult QD
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis
Overall survival of 124 patients who initially received cytokines... | Download Scientific Diagram
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
Overall survival in metastatic renal cell carcinoma patients after... | Download Scientific Diagram
